logo
Opinion - For members of Congress, MAHA isn't just great policy — it's also smart politics

Opinion - For members of Congress, MAHA isn't just great policy — it's also smart politics

Yahoo3 days ago

Believe it: The coalition behind 'Making America Healthy Again' will play an outsized role in deciding the 2026 Congressional midterm elections in more than 500 days from now in November 2026. That's because the issues that go into MAHA close the gender gap and maintain the voter margins with young voters.
But MAHA has been years in the making, going back long before President Trump won his second term and even prior to the political accession of current Secretary of Health and Human Services Robert F. Kennedy, Jr.
My organization is now prioritizing the voters in the top 50 battleground U.S. House seats and 10 U.S. Senate seats, including the open seats in New Hampshire, Michigan, and Minnesota. The voters in all of the prioritized battleground Congressional races fully support the common-sense, nonpartisan health policies about making our nation healthy again. We will be bringing them and their constituent voices to meet in person with their U.S. senators and Representatives in Washington starting next month.
U.S. senators who oppose their constituents' heartfelt, passionate support for these policies will lose in 2026. This includes making epinephrine an over-the-counter drug (something FDA Commissioner Martin Makary voiced support for in his March confirmation hearing) the elimination of taxpayer-funded sodas from the Supplemental Nutrition Assistance Program, expansion of regenerative farming, and elimination of glyphosate herbicides and other poisons in the food supply.
Conversely, senators and representatives, regardless of party, who support their constituents and the policies we work for will earn the support of their constituents on election day.
Our coalition is truly bipartisan, based on an Executive Order issued by a Republican president and implemented by a scion of the Democratic Party. This has helped my organization scale to become the fastest-growing nationwide public health advocacy coalition, which is ready to be activated in a micro-targeted deployment to battleground U.S. House and Senate races in the midterm elections.
Perhaps most importantly, leaders in Congress from both parties support our goals. House Speaker Mike Johnson (R-La.), Minority Leader Hakeem Jeffries (D-N.Y.), Senate Majority Leader John Thune (R-S.D.), and Senate Minority Leader Chuck Schumer (D-N.Y.) are all acutely aware of the power our coalition has now, and all four are working with us in support of their respective conferences.
Why? Because the 50 battleground House seats and 10 U.S. Senate seats will be decided by mere thousands of votes. Our coalition will be a deciding factor in many if not all of these toss-up Congressional election races.
What differentiates our organization from any other entity is our unprecedented structure and confluence with the electorate's mindset and policy priorities. We are free of the corporate groups that traditionally mete out retribution upon those who boldly do what is right. And we have secured the immediate branding of a disruptive force that enjoys trust from voters trust on the policies they care most about.
Don't take our word for it. Every congressional incumbent in a battleground district or state has met with us, and many are relying upon us and our voters to be re-elected.
In more than 30 years of working with Congress and White Houses of both Republican and Democratic political parties, I have never seen so much certainty among congressional leaders that these issues will determine their political fate and build the next congressional majority.
With 522 days to go until election day, each senator and representative working with us understands that his or her race is being won, right now, by MAHA issues and MAHA voters.
Robert K. Houton is founder of the Make America Healthy Again Coalition, is a former U.S. Senate candidate from Maryland and candidate for chair of the Democratic National Committee.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Marjorie Taylor Greene Fumes Over Vaccine Approval: 'Not MAHA at All'
Marjorie Taylor Greene Fumes Over Vaccine Approval: 'Not MAHA at All'

Newsweek

time18 minutes ago

  • Newsweek

Marjorie Taylor Greene Fumes Over Vaccine Approval: 'Not MAHA at All'

Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Marjorie Taylor Greene has spoken out against a new COVID-19 vaccine being approved in the United States, saying the move is "not MAHA at all." Why It Matters Health Secretary Robert F. Kennedy Jr. is facing repeated backlash for some of his positions on health and medicine, including from people who would ordinarily support him. In May, prominent members of the Make America Great Again movement, including Nicole Shanahan, Kennedy's former presidential running mate, and media personality Laura Loomer, spoke out against Kennedy Jr.'s pick for U.S. Surgeon General Casey Means. In March, Kennedy Jr. sparked anger from anti-vax activists when he called on parents to "consult with their healthcare providers to understand their options to get the MMR vaccine," with one saying he is "no different than Fauci." Marjorie Taylor Greene, R-Ga., arrives for a meeting of House Republicans in the Capitol Visitor Center on May 15, 2025. Marjorie Taylor Greene, R-Ga., arrives for a meeting of House Republicans in the Capitol Visitor Center on May 15, 2025. AP What To Know The U.S. Food and Drug Administration (FDA) gave the green light for mNEXSPIKE (mRNA-1283), Moderna's new lower-dose COVID-19 vaccine, on May 31. Greene, the U.S. representative for Georgia's 14th congressional district, shared Moderna's post about the recent approval with the caption: "Not MAHA at all!!! Unreal." Not MAHA at all!!! Unreal. — Rep. Marjorie Taylor Greene🇺🇸 (@RepMTG) June 1, 2025 She was referring to Kennedy Jr.'s movement Make America Healthy Again, whose mission is to "aggressively combat the critical health challenges facing our citizens, including the rising rates of mental health disorders, obesity, diabetes, and other chronic diseases." Newsweek has contacted the United States Department of Health and Human Services outside of office hours, via email, for comment. The new vaccine is set to be used for adults 65 or older or people between the ages of 12 and 64 with at least one or more underlying risk factor as defined by the Centers for Disease Control and Prevention (CDC). Approval for the jab is "based on results from a randomized, observer-blind, active-controlled Phase 3 clinical trial which enrolled approximately 11,400 participants aged 12 years and older," Moderna says. It comes after Kennedy Jr. announced that the CDC is no longer encouraging COVID-19 vaccines for pregnant women and healthy children, marking a shift in federal public health guidance. What People Are Saying Chief Executive Officer of Moderna Stéphane Bancel said in a statement: "The FDA approval of our third product, mNEXSPIKE, adds an important new tool to help protect people at high risk of severe disease from COVID-19. "COVID-19 remains a serious public health threat, with more than 47,000 Americans dying from the virus last year alone. We appreciate the FDA's timely review and thank the entire Moderna team for their hard work and continued commitment to public health." Kennedy Jr. said about the new CDC guidance: "I couldn't be more pleased to announce that as of today the COVID vaccine for healthy children and healthy pregnant women has been removed from the CDC recommended immunization schedule." What Happens Next The new vaccine is expected to be ready for those eligible to take it in time for the 2025-2026 respiratory virus season. You should not get mNEXSPIKE if you had a severe allergic reaction after a previous dose of either mNEXSPIKE, SPIKEVAX (an mRNA vaccine for preventing COVID-19) or any Moderna COVID-19 vaccine or to any ingredient in these vaccines, the company warns.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store